Search Results
Search for other papers by Eyun Song in
Google Scholar
PubMed
Search for other papers by Dong Eun Song in
Google Scholar
PubMed
Search for other papers by Jonghwa Ahn in
Google Scholar
PubMed
Search for other papers by Tae Yong Kim in
Google Scholar
PubMed
Search for other papers by Won Bae Kim in
Google Scholar
PubMed
Search for other papers by Young Kee Shong in
Google Scholar
PubMed
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
include 53% of patients with distant metastasis ( Ibrahimpasic et al. 2017 ). Since then, to the best of our knowledge, research has not been performed using a similar approach regarding these aggressive forms of thyroid cancer, especially regarding
Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
Department of Pathology and Oncology, Medical Faculty, University of Porto, Porto, Portugal
Search for other papers by Valdemar Máximo in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar e Universitário de Coimbra, Medical Faculty, University of Coimbra, Coimbra, Portugal
Search for other papers by Miguel Melo in
Google Scholar
PubMed
Search for other papers by Yingjie Zhu in
Google Scholar
PubMed
Search for other papers by Andrea Gazzo in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
Department of Pathology and Oncology, Medical Faculty, University of Porto, Porto, Portugal
Department of Pathology, Hospital São João, Porto 4200-319, Portugal
Search for other papers by Manuel Sobrinho Simões in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
Search for other papers by Arnaud Da Cruz Paula in
Google Scholar
PubMed
Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal
Department of Pathology and Oncology, Medical Faculty, University of Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
distant metastasis . Cancer Science 111 2163 – 2173 . ( https://doi.org/10.1111/cas.14389 ) Landa I Ibrahimpasic T Boucai L Sinha R Knauf JA Shah RH Dogen S Ricarte-Filho JC Krishnamoorthy GP Xu B , et al. 2016 Genomic and
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea
Search for other papers by Kyungmin Lee in
Google Scholar
PubMed
Search for other papers by Sang-Hyun Lee in
Google Scholar
PubMed
Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science & Technology, Daejeon, Republic of Korea
Search for other papers by Wooil Kim in
Google Scholar
PubMed
Search for other papers by Jangwook Lee in
Google Scholar
PubMed
Search for other papers by Jong-Gil Park in
Google Scholar
PubMed
Search for other papers by Jang-Seong Kim in
Google Scholar
PubMed
Search for other papers by Jung Tae Kim in
Google Scholar
PubMed
Search for other papers by Yea Eun Kang in
Google Scholar
PubMed
Search for other papers by Minho Shong in
Google Scholar
PubMed
Search for other papers by Hyo Jin Lee in
Google Scholar
PubMed
Search for other papers by Jin-Man Kim in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
Daejeon Endo Internal Medicine, Daejeon, Republic of Korea
Search for other papers by Koon Soon Kim in
Google Scholar
PubMed
Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science & Technology, Daejeon, Republic of Korea
Search for other papers by Jeong-Ki Min in
Google Scholar
PubMed
tumor invasion or distant metastasis in most ATC patients at the time of diagnosis. Thus, ATC has a poor prognosis, with a mean survival of 4–12 months from the time of diagnosis ( Granata et al. 2013 ). In such advanced cases, initial ATC treatment is
Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Henry Crayton in
Google Scholar
PubMed
Search for other papers by Katherine Wu in
Google Scholar
PubMed
Search for other papers by David Leong in
Google Scholar
PubMed
Search for other papers by Nazim Bhimani in
Google Scholar
PubMed
Department of Endocrinology, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, New South Wales, Australia
Search for other papers by Matti Gild in
Google Scholar
PubMed
Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
The Kinghorn Cancer Centre, Garvan Institute of Medical Research, St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales, Darlinghurst, New South Wales, Australia
Search for other papers by Anthony Glover in
Google Scholar
PubMed
/or metastatic disease at diagnosis, persistence disease, recurrent disease, distant metastasis, DFS (disease-free survival) and DSM. Quality and risk of bias assessment of eligible studies The Newcastle–Ottawa Quality Assessment Form for cohort studies
Search for other papers by Segolene Hescot in
Google Scholar
PubMed
Search for other papers by Abir Al Ghuzlan in
Google Scholar
PubMed
Search for other papers by Theophraste Henry in
Google Scholar
PubMed
Search for other papers by Hala Sheikh-Alard in
Google Scholar
PubMed
Search for other papers by Livia Lamartina in
Google Scholar
PubMed
Search for other papers by Isabelle Borget in
Google Scholar
PubMed
Search for other papers by Julien Hadoux in
Google Scholar
PubMed
Search for other papers by Eric Baudin in
Google Scholar
PubMed
Search for other papers by Corinne Dupuy in
Google Scholar
PubMed
Search for other papers by Alyaksandr V Nikitski in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Department of Endocrinology, Hôpitaux Universitaires de Genève, Geneva, Switzerland
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
risk groups (MRGs). The risk stratification was based on the associations between molecular alterations and the probability of disease recurrence or distant metastasis and OS ( Xing et al. 2013 , Yip et al. 2015 , 2021 , Haugen et al. 2016
Search for other papers by Hong-Jun Song in
Google Scholar
PubMed
Department of Nuclear Medicine, Postgraduate Department, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China
Search for other papers by Yan-Li Xue in
Google Scholar
PubMed
Department of Nuclear Medicine, Postgraduate Department, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China
Search for other papers by Yan-Hong Xu in
Google Scholar
PubMed
Search for other papers by Zhong-Ling Qiu in
Google Scholar
PubMed
Search for other papers by Quan-Yong Luo in
Google Scholar
PubMed
mortality in patients with DTC are age over 45 years and the involvement of multiple organs, both are independently associated with cancer mortality ( Ruegemer et al . 1988 ). The common distant metastasis sites (lung and bone) from DTC usually draw
Search for other papers by Huy Gia Vuong in
Google Scholar
PubMed
Search for other papers by Toru Odate in
Google Scholar
PubMed
Search for other papers by Hanh T T Ngo in
Google Scholar
PubMed
Search for other papers by Thong Quang Pham in
Google Scholar
PubMed
Search for other papers by Thao T K Tran in
Google Scholar
PubMed
Search for other papers by Kunio Mochizuki in
Google Scholar
PubMed
Search for other papers by Tadao Nakazawa in
Google Scholar
PubMed
Search for other papers by Ryohei Katoh in
Google Scholar
PubMed
Search for other papers by Tetsuo Kondo in
Google Scholar
PubMed
category in the most recent guidelines ( Wells et al . 2015 ). Several clinicopathological parameters have been reported to be indicators of poor prognosis in MTCs including age, male gender and distant metastasis ( Raue et al . 1993 , Gulben et al
Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea
Search for other papers by Hyun Ho Han in
Google Scholar
PubMed
Search for other papers by Baek Gil Kim in
Google Scholar
PubMed
Search for other papers by Joo Hyun Lee in
Google Scholar
PubMed
Search for other papers by Suki Kang in
Google Scholar
PubMed
Search for other papers by Ji Eun Kim in
Google Scholar
PubMed
Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea
Severance Biomedical Science Institute (SBSI), Yonsei University College of Medicine, Seoul, South Korea
Global 5-5-10 System Biology, Yonsei University, Seoul, South Korea
Search for other papers by Nam Hoon Cho in
Google Scholar
PubMed
antiestrogen endocrine therapy, increased ANGPT2 level was associated with a significantly decreased probability of distant metastasis-free survival (DMFS) ( Fig. 7A ). For those without endocrine therapy, contrastingly, ANGPT2 level was not associated with
Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences ‘Mario Serio’, University of Florence, Florence, Italy
Search for other papers by Clotilde Sparano in
Google Scholar
PubMed
Search for other papers by Yann Godbert in
Google Scholar
PubMed
Search for other papers by Marie Attard in
Google Scholar
PubMed
Search for other papers by Christine Do Cao in
Google Scholar
PubMed
Search for other papers by Slimane Zerdoud in
Google Scholar
PubMed
Search for other papers by Nathalie Roudaut in
Google Scholar
PubMed
Search for other papers by Charlotte Joly in
Google Scholar
PubMed
Search for other papers by Amandine Berdelou in
Google Scholar
PubMed
Search for other papers by Julien Hadoux in
Google Scholar
PubMed
Search for other papers by Livia Lamartina in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
, advanced disease with distant metastasis showed the worse prognosis, with a 1-year survival odds of 8.2% ( Smallridge et al. 2012 ). The main breakthrough of the last three decades in the treatment of ATC is the use of a dabrafenib–trametinib combination
Department of Nuclear Medicine, Department of Internal Medicine, Medical Research Institute
Search for other papers by Kyoungjune Pak in
Google Scholar
PubMed
Department of Nuclear Medicine, Department of Internal Medicine, Medical Research Institute
Search for other papers by Seong-Jang Kim in
Google Scholar
PubMed
Department of Nuclear Medicine, Department of Internal Medicine, Medical Research Institute
Search for other papers by In Joo Kim in
Google Scholar
PubMed
Department of Nuclear Medicine, Department of Internal Medicine, Medical Research Institute
Search for other papers by Bo Hyun Kim in
Google Scholar
PubMed
Department of Nuclear Medicine, Department of Internal Medicine, Medical Research Institute
Search for other papers by Sang Soo Kim in
Google Scholar
PubMed
Department of Nuclear Medicine, Department of Internal Medicine, Medical Research Institute
Search for other papers by Yun Kyung Jeon in
Google Scholar
PubMed
& Grab-Duntas 2006 ). Prognostic factors for DTCs are well known. Age, gender, family history, tumor size, multifocality, extrathyroidal extension (EE), tumor subtype, vascular invasion, lymph node (LN) metastasis, distant metastasis, and low or no iodine